Medicine and Science, that's me! My name is Giusy Davino and I'm just a 22-years-old medical student in University of Salerno (Italy) with internet access!
"Isn't it strange
That princes and kings
And clowns that caper
In sawdust rings
And common people
Like you and me
Are builders for eternity?
Each is given a bag of tools,
A shapeless mass,
A book of rules;
And each must make -
Ere life is flown -
A stumbling block
Or a stepping stone."

 

HIV: First pediatric vaccination of Vertically Infected Children in Italy - First Pediatric Randomised Trial (PEDVAC).
A pediatric vaccination was successfully tested on twenty vertically HIV-infected children, 6–16 years of age, with stable viral load control and CD4+ values above 400 cells/mm3, at the Pediatric Hospital of the Child Jesus in Rome.
The research is published on PLOS one and it was led by immunologist Paolo Palma, from Paolo Rossi’s team.
Ten subjects continued their ongoing antiretroviral treatment (ART) and ten were immunized with a HIV-DNA vaccine in addition to their previous therapy (ART and vaccine). The genetic vaccine represented HIV-1 subtypes A, B and C, encoded Env, Rev, Gag and RT and had no additional adjuvant. Immunizations took place at weeks 0, 4 and 12, with a boosting dose at week 36. Monitoring was performed until week 60 and extended to week 96.
The study demonstrates the feasibility, safety and moderate immunogenicity of genetic vaccination in vertically HIV-infected children, paving the way for amplified immunotherapeutic approaches in the pediatric population.
To read more: PLOS one link.

HIV: First pediatric vaccination of Vertically Infected Children in Italy - First Pediatric Randomised Trial (PEDVAC).

A pediatric vaccination was successfully tested on twenty vertically HIV-infected children, 6–16 years of age, with stable viral load control and CD4+ values above 400 cells/mm3, at the Pediatric Hospital of the Child Jesus in Rome.

The research is published on PLOS one and it was led by immunologist Paolo Palma, from Paolo Rossi’s team.

Ten subjects continued their ongoing antiretroviral treatment (ART) and ten were immunized with a HIV-DNA vaccine in addition to their previous therapy (ART and vaccine). The genetic vaccine represented HIV-1 subtypes A, B and C, encoded Env, Rev, Gag and RT and had no additional adjuvant. Immunizations took place at weeks 0, 4 and 12, with a boosting dose at week 36. Monitoring was performed until week 60 and extended to week 96.

The study demonstrates the feasibility, safety and moderate immunogenicity of genetic vaccination in vertically HIV-infected children, paving the way for amplified immunotherapeutic approaches in the pediatric population.

To read more: PLOS one link.

  1. theworldagainstseth reblogged this from cacajao
  2. cacajao reblogged this from jewsee-medicalstudent
  3. 53rdcenturyhero reblogged this from the-inceptionist
  4. bangoldguk reblogged this from jewsee-medicalstudent
  5. kensatucky reblogged this from scienceyoucanlove
  6. octagonperfectionist reblogged this from scienceyoucanlove
  7. gertrudejinlges reblogged this from scienceyoucanlove
  8. voiceofthequietuniverse reblogged this from scienceyoucanlove
  9. theaffluenza reblogged this from scienceyoucanlove
  10. midwayuponthisjourney reblogged this from annieskywalker
  11. avalancheawakening reblogged this from worldofone
  12. idoscience reblogged this from thecraftychemist
  13. yolopig reblogged this from scienceyoucanlove
  14. lonewalker reblogged this from jewsee-medicalstudent
  15. fragmentedrecords reblogged this from scienceyoucanlove
  16. nereid-blood reblogged this from passthechloroform
  17. passthechloroform reblogged this from thecraftychemist
  18. annieskywalker reblogged this from thecraftychemist
  19. maximilian369 reblogged this from jewsee-medicalstudent
  20. thecraftychemist reblogged this from anothermeanmememachine
  21. jet-foam reblogged this from terri314159265ing
  22. terri314159265ing reblogged this from scienceyoucanlove
  23. runningamongthestars reblogged this from literatureoftruth